Proactiveinvestors United Kingdom AstraZeneca https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom AstraZeneca RSS feed en Sun, 25 Aug 2019 11:59:07 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[News - Amryt Pharma: The AIM drug developer potentially sitting on a US$100mln piece of paper ]]> https://www.proactiveinvestors.co.uk/companies/news/901340/amryt-pharma-the-aim-drug-developer-potentially-sitting-on-a-us100mln-piece-of-paper-901340.html Thu, 22 Aug 2019 15:09:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901340/amryt-pharma-the-aim-drug-developer-potentially-sitting-on-a-us100mln-piece-of-paper-901340.html <![CDATA[News - AstraZeneca scores another regulatory win in China for roxadustat anaemia drug ]]> https://www.proactiveinvestors.co.uk/companies/news/901301/astrazeneca-scores-another-regulatory-win-in-china-for-roxadustat-anaemia-drug-901301.html Thu, 22 Aug 2019 08:55:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901301/astrazeneca-scores-another-regulatory-win-in-china-for-roxadustat-anaemia-drug-901301.html <![CDATA[RNS press release - Roxadustat approved in China for the treatment of ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190822070015_14198204/ Thu, 22 Aug 2019 07:00:15 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190822070015_14198204/ <![CDATA[RNS press release - AstraZeneca agrees to buy US FDA Priority Review ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190822070009_14198188/ Thu, 22 Aug 2019 07:00:09 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190822070009_14198188/ <![CDATA[News - FTSE 100 closes lower as sterling's strength hits the index after Merkel back-stop comments ]]> https://www.proactiveinvestors.co.uk/companies/news/901279/ftse-100-closes-lower-as-sterling-s-strength-hits-the-index-after-merkel-back-stop-comments-901279.html Thu, 22 Aug 2019 06:48:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901279/ftse-100-closes-lower-as-sterling-s-strength-hits-the-index-after-merkel-back-stop-comments-901279.html <![CDATA[News - Investor Update: Asiamet signs agreement with China Nonferrous Metals ]]> https://www.proactiveinvestors.co.uk/companies/news/901217/investor-update-asiamet-signs-agreement-with-china-nonferrous-metals-901217.html Wed, 21 Aug 2019 09:03:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901217/investor-update-asiamet-signs-agreement-with-china-nonferrous-metals-901217.html <![CDATA[News - AstraZeneca’s cancer drug combo stumbles in phase III lung cancer trial ]]> https://www.proactiveinvestors.co.uk/companies/news/901207/astrazenecas-cancer-drug-combo-stumbles-in-phase-iii-lung-cancer-trial-901207.html Wed, 21 Aug 2019 07:56:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901207/astrazenecas-cancer-drug-combo-stumbles-in-phase-iii-lung-cancer-trial-901207.html <![CDATA[RNS press release - Update on the Phase III NEPTUNE trial ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190821070002_14196475/ Wed, 21 Aug 2019 07:00:02 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190821070002_14196475/ <![CDATA[News - AstraZeneca nears £100bn market cap as remarkable drug pipeline turnaround continues ]]> https://www.proactiveinvestors.co.uk/companies/news/901158/astrazeneca-nears-100bn-market-cap-as-remarkable-drug-pipeline-turnaround-continues-901158.html Tue, 20 Aug 2019 15:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901158/astrazeneca-nears-100bn-market-cap-as-remarkable-drug-pipeline-turnaround-continues-901158.html <![CDATA[News - AstraZeneca pumps higher as Farxiga shows benefit in late-stage heart-failure study ]]> https://www.proactiveinvestors.co.uk/companies/news/901120/astrazeneca-pumps-higher-as-farxiga-shows-benefit-in-late-stage-heart-failure-study-901120.html Tue, 20 Aug 2019 09:38:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901120/astrazeneca-pumps-higher-as-farxiga-shows-benefit-in-late-stage-heart-failure-study-901120.html <![CDATA[News - Investor Update: Argo Blockchain agrees deal to expand electricity supply by 357% ]]> https://www.proactiveinvestors.co.uk/companies/news/901116/investor-update-argo-blockchain-agrees-deal-to-expand-electricity-supply-by-357-901116.html Tue, 20 Aug 2019 09:17:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901116/investor-update-argo-blockchain-agrees-deal-to-expand-electricity-supply-by-357-901116.html <![CDATA[RNS press release - Farxiga met primary endpoint in landmark Phase III ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190820070011_14194766/ Tue, 20 Aug 2019 07:00:11 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190820070011_14194766/ <![CDATA[News - FTSE 100 closes in red as trader optimism swiftly fizzles out ]]> https://www.proactiveinvestors.co.uk/companies/news/901092/ftse-100-closes-in-red-as-trader-optimism-swiftly-fizzles-out-901092.html Tue, 20 Aug 2019 06:31:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901092/ftse-100-closes-in-red-as-trader-optimism-swiftly-fizzles-out-901092.html <![CDATA[RNS press release - Directorate Change ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190819070005_14193056/ Mon, 19 Aug 2019 07:00:05 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190819070005_14193056/ <![CDATA[News - AstraZeneca’s Lynparza meets primary endpoint in late-stage ovarian cancer trial ]]> https://www.proactiveinvestors.co.uk/companies/news/900745/astrazenecas-lynparza-meets-primary-endpoint-in-late-stage-ovarian-cancer-trial-900745.html Wed, 14 Aug 2019 12:58:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/900745/astrazenecas-lynparza-meets-primary-endpoint-in-late-stage-ovarian-cancer-trial-900745.html <![CDATA[RNS press release - Lynparza Phase III PAOLA-1 trial met primary endpo ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190814070008_14187893/ Wed, 14 Aug 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190814070008_14187893/ <![CDATA[RNS press release - Calquence granted US Breakthrough Therapy Designat ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190814070007_14187889/ Wed, 14 Aug 2019 07:00:07 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190814070007_14187889/ <![CDATA[RNS press release - Amendment: Tagrisso significantly improves overall ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190809092852_14183327/ Fri, 09 Aug 2019 09:28:52 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190809092852_14183327/ <![CDATA[RNS press release - Tagrisso significantly improves overall survival ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190809070004_14182659/ Fri, 09 Aug 2019 07:00:04 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190809070004_14182659/ <![CDATA[News - FTSE 100 closes higher as risk-on investor mood returns, trade war fears fade ]]> https://www.proactiveinvestors.co.uk/companies/news/900339/ftse-100-closes-higher-as-risk-on-investor-mood-returns-trade-war-fears-fade-900339.html Thu, 08 Aug 2019 08:38:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/900339/ftse-100-closes-higher-as-risk-on-investor-mood-returns-trade-war-fears-fade-900339.html <![CDATA[News - Hargreaves Lansdown results in the spotlight in wake of Woodford scandal ]]> https://www.proactiveinvestors.co.uk/companies/news/900287/hargreaves-lansdown-results-in-the-spotlight-in-wake-of-woodford-scandal-900287.html Wed, 07 Aug 2019 12:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/900287/hargreaves-lansdown-results-in-the-spotlight-in-wake-of-woodford-scandal-900287.html <![CDATA[RNS press release - Lynparza Phase III PROfound trial in HRR* ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190807070006_14179024/ Wed, 07 Aug 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190807070006_14179024/ <![CDATA[RNS press release - Forxiga label updated in the EU in type-2 diabetes ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190805070006_14175508/ Mon, 05 Aug 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190805070006_14175508/ <![CDATA[RNS press release - Total Voting Rights ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190801150001_14173164/ Thu, 01 Aug 2019 15:00:01 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190801150001_14173164/ <![CDATA[News - AstraZeneca’s market value swells by £4bn after forecast-busting second-quarter results ]]> https://www.proactiveinvestors.co.uk/companies/news/224482/astrazenecas-market-value-swells-by-4bn-after-forecast-busting-second-quarter-results-224482.html Thu, 25 Jul 2019 08:35:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/224482/astrazenecas-market-value-swells-by-4bn-after-forecast-busting-second-quarter-results-224482.html <![CDATA[RNS press release - AZN: H1 2019 Results ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190725070011_14162260/ Thu, 25 Jul 2019 07:00:11 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190725070011_14162260/ <![CDATA[News - FTSE 100 closes in red Thursday as ECB update underwhelms ]]> https://www.proactiveinvestors.co.uk/companies/news/224468/ftse-100-closes-in-red-thursday-as-ecb-update-underwhelms-224468.html Thu, 25 Jul 2019 06:51:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/224468/ftse-100-closes-in-red-thursday-as-ecb-update-underwhelms-224468.html <![CDATA[News - Day ahead preview: Unilever, National Express, Diageo, ECB ]]> https://www.proactiveinvestors.co.uk/companies/news/224427/day-ahead-preview-unilever-national-express-diageo-ecb-224427.html Wed, 24 Jul 2019 12:11:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/224427/day-ahead-preview-unilever-national-express-diageo-ecb-224427.html <![CDATA[News - GSK names former AstraZeneca finance boss as new chairman ]]> https://www.proactiveinvestors.co.uk/companies/news/224421/gsk-names-former-astrazeneca-finance-boss-as-new-chairman-224421.html Wed, 24 Jul 2019 10:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/224421/gsk-names-former-astrazeneca-finance-boss-as-new-chairman-224421.html <![CDATA[News - ITV investors hope for Love Island boost amid tough ad market ]]> https://www.proactiveinvestors.co.uk/companies/news/224213/itv-investors-hope-for-love-island-boost-amid-tough-ad-market-224213.html Fri, 19 Jul 2019 12:32:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/224213/itv-investors-hope-for-love-island-boost-amid-tough-ad-market-224213.html <![CDATA[News - GlaxoSmithKline edges higher as Zejula passes late-stage ovarian cancer study with flying colours ]]> https://www.proactiveinvestors.co.uk/companies/news/223894/glaxosmithkline-edges-higher-as-zejula-passes-late-stage-ovarian-cancer-study-with-flying-colours-223894.html Mon, 15 Jul 2019 08:45:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/223894/glaxosmithkline-edges-higher-as-zejula-passes-late-stage-ovarian-cancer-study-with-flying-colours-223894.html <![CDATA[RNS press release - Update on US regulatory decision for Farxiga ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190715070006_14148529/ Mon, 15 Jul 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190715070006_14148529/ <![CDATA[News - US regulators grant orphan drug status to AstraZeneca’s Imfinzi cancer drug ]]> https://www.proactiveinvestors.co.uk/companies/news/223812/us-regulators-grant-orphan-drug-status-to-astrazenecas-imfinzi-cancer-drug-223812.html Fri, 12 Jul 2019 08:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/223812/us-regulators-grant-orphan-drug-status-to-astrazenecas-imfinzi-cancer-drug-223812.html <![CDATA[RNS press release - Imfinzi granted US Orphan Drug Designation for ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190712070003_14145979/ Fri, 12 Jul 2019 07:00:03 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190712070003_14145979/ <![CDATA[RNS press release - Total Voting Rights ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190701150001_14131813/ Mon, 01 Jul 2019 15:00:01 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190701150001_14131813/ <![CDATA[News - AstraZeneca gets two positive opinions from European Medicines Agency committee ]]> https://www.proactiveinvestors.co.uk/companies/news/223127/astrazeneca-gets-two-positive-opinions-from-european-medicines-agency-committee-223127.html Mon, 01 Jul 2019 09:45:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/223127/astrazeneca-gets-two-positive-opinions-from-european-medicines-agency-committee-223127.html <![CDATA[RNS press release - Forxiga receives positive EU CHMP opinion for ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190701070008_14130281/ Mon, 01 Jul 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190701070008_14130281/ <![CDATA[RNS press release - Imfinzi improves overall survival at interim ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190627070012_14127257/ Thu, 27 Jun 2019 07:00:12 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190627070012_14127257/ <![CDATA[RNS press release - Bevespi Aerosphere approved by the Japanese ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190619070004_14115843/ Wed, 19 Jun 2019 07:00:04 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190619070004_14115843/ <![CDATA[News - AstraZeneca gets EU approval for Lynparza as ovarian cancer treatment ]]> https://www.proactiveinvestors.co.uk/companies/news/222317/astrazeneca-gets-eu-approval-for-lynparza-as-ovarian-cancer-treatment-222317.html Tue, 18 Jun 2019 09:20:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/222317/astrazeneca-gets-eu-approval-for-lynparza-as-ovarian-cancer-treatment-222317.html <![CDATA[RNS press release - Lynparza approved in the EU for 1st-line ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190618070012_14114121/ Tue, 18 Jun 2019 07:00:12 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190618070012_14114121/ <![CDATA[News - AstraZeneca sees further encouraging effects from leukaemia treatment Calquence ]]> https://www.proactiveinvestors.co.uk/companies/news/222223/astrazeneca-sees-further-encouraging-effects-from-leukaemia-treatment-calquence-222223.html Mon, 17 Jun 2019 09:32:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/222223/astrazeneca-sees-further-encouraging-effects-from-leukaemia-treatment-calquence-222223.html <![CDATA[RNS press release - Calquence significantly prolonged the time patient ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190617070006_14112397/ Mon, 17 Jun 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190617070006_14112397/ <![CDATA[RNS press release - Publication of a Prospectus ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190612164504_14108763/ Wed, 12 Jun 2019 16:45:04 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190612164504_14108763/ <![CDATA[News - AstraZeneca drug for chronic lymphocytic leukaemia successfully navigates phase III trial ]]> https://www.proactiveinvestors.co.uk/companies/news/221615/astrazeneca-drug-for-chronic-lymphocytic-leukaemia-successfully-navigates-phase-iii-trial-221615.html Thu, 06 Jun 2019 07:59:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/221615/astrazeneca-drug-for-chronic-lymphocytic-leukaemia-successfully-navigates-phase-iii-trial-221615.html <![CDATA[RNS press release - Calquence Phase III ELEVATE-TN trial met primary ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190606070007_14100510/ Thu, 06 Jun 2019 07:00:07 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190606070007_14100510/ <![CDATA[RNS press release - Block listing Interim Review ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190603150005_14096607/ Mon, 03 Jun 2019 15:00:05 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190603150005_14096607/ <![CDATA[News - AstraZeneca reports positive results from trial of pancreatic cancer treatment ]]> https://www.proactiveinvestors.co.uk/companies/news/221371/astrazeneca-reports-positive-results-from-trial-of-pancreatic-cancer-treatment-221371.html Mon, 03 Jun 2019 08:35:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/221371/astrazeneca-reports-positive-results-from-trial-of-pancreatic-cancer-treatment-221371.html <![CDATA[RNS press release - Lynparza nearly doubled time patients lived with ]]> https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190603070009_14095174/ Mon, 03 Jun 2019 07:00:09 +0100 https://www.proactiveinvestors.co.uk/companies/rns/3063/LSE20190603070009_14095174/ <![CDATA[News - FTSE 100 closes higher despite continued trade worries ]]> https://www.proactiveinvestors.co.uk/companies/news/221352/ftse-100-closes-higher-despite-continued-trade-worries-221352.html Mon, 03 Jun 2019 06:34:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/221352/ftse-100-closes-higher-despite-continued-trade-worries-221352.html